Dr. Jerkins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-5000Fax+1 414-805-6815
Education & Training
University of California (Irvine)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Kettering Health Network/Kettering Medical CenterResidency, Internal Medicine, 2007 - 2011
Loma Linda University School of MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2011 - Present
TN State Medical License 2023 - 2026
WI State Medical License 2016 - 2023
OH State Medical License 2007 - 2012- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- High rates of MHC mismatches in HLA matched unrelated donor/recipient pairs and potential impact on hematopoietic cell transplant outcome.David Sayer, James Nytes, James H Jerkins, Matthew W Anderson
Human Immunology. 2024-12-05 - Progressive multifocal leukoencephalopathy after CAR-T cell therapy.Michael Montoya, Hannah J Harmsen, Brittney Baer, Nancy Long, Amy Messimore
Bone Marrow Transplantation. 2024-12-01 - Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.Marshall D Winget, Katie Gatwood, Reena Jayani, Eden Biltibo, Andrew Jallouk
Transplantation and Cellular Therapy. 2024-10-01
Press Mentions
Alpha-1-Antitrypsin for the Treatment of Steroid-Refractory Acute Gastrointestinal Graft-Versus-Host DiseaseJuly 12th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
